Procept BioRobotics Corp (NASDAQ: PRCT) is 92.75% higher on its value in year-to-date trading and has touched a low of $39.48 and a high of $103.81 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PRCT stock was last observed hovering at around $82.14 in the last trading session, with the day’s loss setting it -1.36%.
Currently trading at $80.78, the stock is -12.80% and -7.74% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.09 million and changing -1.66% at the moment leaves the stock 15.69% off its SMA200. PRCT registered 92.24% gain for a year compared to 6-month gain of 34.81%. The firm has a 50-day simple moving average (SMA 50) of $87.4254 and a 200-day simple moving average (SMA200) of $69.65565.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -13.67% loss in the last 1 month and extending the period to 3 months gives it a -4.95%, and is -10.05% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.05% over the week and 4.30% over the month.
Procept BioRobotics Corp (PRCT) has around 626 employees, a market worth around $4.39B and $199.84M in sales. Profit margin for the company is -50.07%. Distance from 52-week low is 104.61% and -22.18% from its 52-week high. The company has generated returns on investments over the last 12 months (-31.27%).
with sales reaching $66.79M over the same period.The EPS is expected to grow by 22.27% this year, but quarterly earnings will post 64.49% year-over-year. Quarterly sales are estimated to grow 53.25% in year-over-year returns.
352.0 institutions hold shares in Procept BioRobotics Corp (PRCT), with institutional investors hold 90.66% of the company’s shares. The shares outstanding are 52.15M, and float is at 51.55M with Short Float at 11.81%. Institutions hold 86.57% of the Float.
The top institutional shareholder in the company is FMR LLC with over 7.29 million shares valued at $445.33 million. The investor’s holdings represent 14.2907 of the PRCT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 4.71 million shares valued at $287.87 million to account for 9.2375 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 3.49 million shares representing 6.8328 and valued at over $212.93 million, while ALLIANCEBERNSTEIN L.P. holds 3.5466 of the shares totaling 1.81 million with a market value of $110.52 million.
Procept BioRobotics Corp (PRCT) Insider Activity
The most recent transaction is an insider sale by Zadno Reza, the company’s President, CEO. SEC filings show that Zadno Reza sold 26,423 shares of the company’s common stock on Dec 04 ’24 at a price of $97.22 per share for a total of $2.57 million. Following the sale, the insider now owns 0.15 million shares.
Procept BioRobotics Corp disclosed in a document filed with the SEC on Dec 04 ’24 that Nouri Alaleh (EVP, CLO, CORP. SEC.) sold a total of 28,092 shares of the company’s common stock. The trade occurred on Dec 04 ’24 and was made at $97.13 per share for $2.73 million. Following the transaction, the insider now directly holds 52472.0 shares of the PRCT stock.
Still, SEC filings show that on Dec 04 ’24, REZA ZADNO (Director) Proposed Sale 26,423 shares at an average price of $96.48 for $2.55 million. The insider now directly holds shares of Procept BioRobotics Corp (PRCT).
